|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Breast Cancer |
| Authors Name: | Pooja Narendra Patil , Soniya sukhdev Satpute |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_185447
|
| Published Paper Id: | IJNRD2301008 |
| Published In: | Volume 8 Issue 1, January-2023 |
| DOI: | |
| Abstract: | Breast cancer is the most frequent most cancers in ladies in developed countries, and 12% of breast most cancers happens in women 20-34 years. Survival from breast cancer has appreciably improved, and the doable late consequences of therapy and the have an impact on on satisfactory of lifestyles have grow to be increasingly important. Young ladies constitute a minority of breast most cancers patients, however often have distinct concerns and issues compared with older women, consisting of queries regarding fertility, contraception and pregnancy. Further, they are greater probably than older women to have questions related to doable aspect results of therapy and danger of relapse or a new primary. In addition, many will have signs and symptoms associated with cure and they present a administration challenge. |
| Keywords: | Key words(Breast cancer,DCIS, HER2 ,Immune Therapy,Chemotherapy) |
| Cite Article: | "Breast Cancer ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 1, page no.a59-a64, January-2023, Available :http://www.ijnrd.org/papers/IJNRD2301008.pdf |
| Downloads: | 000118753 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2301008 Registration ID: 185447 Published In: Volume 8 Issue 1, January-2023 DOI (Digital Object Identifier): Page No: a59-a64 Country: Nashik , Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2301008 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2301008 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn